Read + Share
Amedeo Smart
Independent Medical Education
Zhou C, Huang R, Yuan Y, Schnell P, et al. Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers. Oncologist 2025;30:oyaf177.PMID: 40578840
Email
LinkedIn
Privacy Policy